The Journal of Immunology, Vol 149, Issue 4 1276-1282, Copyright © 1992 by American Association of Immunologists

ARTICLES

Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage

CR Faltynek, S Wang, D Miller, E Young, L Tiberio, K Kross, M Kelley and E Kloszewski
Department of Immunopharmacology, Sterling Winthrop Pharmaceuticals Research Division, Malvern, PA 19355.

In vitro experiments performed by several investigators have demonstrated that IL-7 is a growth factor for immature B lymphocytes, thymocytes, and mature T lymphocytes. To evaluate the potential therapeutic use for human rIL-7 (rhuIL-7) as a hematopoietin, we have studied the in vivo hematopoietic effects of rhuIL-7 in mice. In these experiments, sublethally irradiated and normal mice were treated with or without rhuIL-7 for up to 26 days. Administration of rhuIL-7 significantly increased the white blood cell count in the peripheral blood and spleen in both normal and irradiated mice. Treatment with rhuIL-7 also accelerated lymphocytic recovery in irradiated mice. Precursor and mature B lymphocytes showed the greatest expansion in response to rhuIL-7 administration, with smaller increases in T lymphocytes being observed. In mice recovering from high dose irradiation, rhuIL-7 treatment resulted in preferential expansion of CD8+ T lymphocytes and more rapid normalization of the CD4/CD8 ratios. Differential analysis of peripheral blood smears demonstrated that rhuIL-7 also increased the numbers of immature granulocytes in both normal and irradiated mice. Moreover, administration of rhuIL-7 to normal, irradiated, cyclophosphamide-pretreated, or 5-fluorouracil- pretreated mice increased the number of acetylcholinesterase-positive megakaryocytes in the spleen, but not the bone marrow. Therefore, although the major in vivo effects of rhuIL-7 were on cells of the lymphocytic lineage, rhuIL-7 also increased the numbers of some immature cells of the myeloid lineage.

This article has been cited by other articles:

				G. L. Goldberg, O. Alpdogan, S. J. Muriglan, M. V. Hammett, M. K. Milton, J. M. Eng, V. M. Hubbard, A. Kochman, L. M. Willis, A. S. Greenberg, et al. Enhanced Immune Reconstitution by Sex Steroid Ablation following Allogeneic Hemopoietic Stem Cell Transplantation J. Immunol., June 1, 2007; 178(11): 7473 - 7484. [Abstract] [Full Text] [PDF]

				F. B. Aiello, J. R. Keller, K. D. Klarmann, G. Dranoff, R. Mazzucchelli, and S. K. Durum IL-7 Induces Myelopoiesis and Erythropoiesis J. Immunol., February 1, 2007; 178(3): 1553 - 1563. [Abstract] [Full Text] [PDF]

				H. Yang, X. Sun, E. Q. Haxhija, and D. H. Teitelbaum Intestinal epithelial cell-derived interleukin-7: a mechanism for the alteration of intraepithelial lymphocytes in a mouse model of total parenteral nutrition Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G84 - G91. [Abstract] [Full Text] [PDF]

				N. Dainiak, J. K. Waselenko, J. O. Armitage, T. J. MacVittie, and A. M. Farese The Hematologist and Radiation Casualties Hematology, January 1, 2003; 2003(1): 473 - 496. [Abstract] [Full Text] [PDF]

				A. M. Farese, D. B. Casey, W. G. Smith, R. M. Vigneulle, J. P. McKearn, and T. J. MacVittie Leridistim, a Chimeric Dual G-CSF and IL-3 Receptor Agonist, Enhances Multilineage Hematopoietic Recovery in a Nonhuman Primate Model of Radiation-Induced Myelosuppression: Effect of Schedule, Dose, and Route of Administration Stem Cells, November 1, 2001; 19(6): 522 - 533. [Abstract] [Full Text]

				O. Alpdogan, C. Schmaltz, S. J. Muriglan, B. J. Kappel, M.-A. Perales, J. A. Rotolo, J. A. Halm, B. E. Rich, and M. R. M. van den Brink Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease Blood, October 1, 2001; 98(7): 2256 - 2265. [Abstract] [Full Text] [PDF]

				L. A. Geiselhart, C. A. Humphries, T. A. Gregorio, S. Mou, J. Subleski, and K. L. Komschlies IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation J. Immunol., March 1, 2001; 166(5): 3019 - 3027. [Abstract] [Full Text] [PDF]

				U. von Freeden-Jeffry, N. Davidson, R. Wiler, M. Fort, S. Burdach, and R. Murray IL-7 Deficiency Prevents Development of a Non-T Cell Non-B Cell-Mediated Colitis J. Immunol., November 15, 1998; 161(10): 5673 - 5680. [Abstract] [Full Text] [PDF]

				A. Varas, A. Vicente, R. Sacedon, and A. G. Zapata Interleukin-7 Influences the Development of Thymic Dendritic Cells Blood, July 1, 1998; 92(1): 93 - 100. [Abstract] [Full Text] [PDF]